Protease-activated receptor-1 regulates cytokine production and induces the suppressor of cytokine signaling-3 in microglia

International Journal of Molecular Medicine

Volumn 24, Issue 3, 2009, Pages 367-371

  Fabrizi, Cinzia ^a   Pompili, Elena ^a   Panetta, Barbara ^a   Nori, Stefania Lucia ^b   Fumagalli, Lorenzo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Inflammation; Microglia; Protease activated receptor 1

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEINASE ACTIVATED RECEPTOR 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MESSENGER RNA; OLIGOPEPTIDE; SER PHE PHE LEU ARG ASN; SER-PHE-PHE-LEU-ARG-ASN; SOCS3 PROTEIN, RAT; SUPPRESSOR OF CYTOKINE SIGNALING;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RAT;

ANIMALS; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION REGULATION; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; OLIGOPEPTIDES; RATS; RECEPTOR, PAR-1; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70349574106     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000241     Document Type: Article

References (38)

1. Coughlin SR: Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 3: 1800-1814, 2005.
2. Arora P, Ricks TK and Trejo J: Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J Cell Sci 120: 921-928, 2007.
3. Turgeon VL, Lloyd ED, Wang S, Festoff BW and Houenou LJ: Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation. J Neurosci 18: 6882-6891, 1998.
4. Gingrich MB, Junge CE, Lyuboslavsky P and Traynelis SF: Potentiation of NMDA receptor function by the serine protease thrombin. J Neurosci 20: 4582-4595, 2000.
5. Pforte C, Henrich-Noack P, Baldauf K and Reymann KG: Increase in proliferation and gliogenesis but decrease of early neurogenesis in the rat forebrain shortly after transient global ischemia. Neuroscience 136: 1133-1146, 2005.
6. Laskowski A, Reiser G and Reymann KG: Protease-activated receptor-1 induces generation of new microglia in the dentate gyrus of traumatised hippocampal slice cultures. Neurosci Lett 415: 17-21, 2007.
7. Henrich-Noack P, Riek-Burchardt M, Baldauf K, Reiser G and Reymann KG: Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra. Brain Res 1070: 232-241, 2006.
8. Junge CE, Sugawara T, Mannaioni G, Alagarsamy S, Conn PJ, Brat DJ, Chan PH and Traynelis SF: The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia. Proc Natl Acad Sci USA 100: 13019-13024, 2003.
9. Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG and Reiser G: The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 97: 2264-2269, 2000.
10. Vaughan PJ, Pike CJ, Cotman CW and Cunningham DD: Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 15: 5389-5401, 1995.
11. Pike CJ, Vaughan PJ, Cunningham DD and Cotman CW: Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by beta-amyloid in vitro. J Neurochem 66: 1374-1382, 1996.
12. Kim KY, Kim MY, Choi HS, Jin BK, Kim SU and Lee YB: Thrombin induces IL-10 production in microglia as a negative feedback regulator of TNF-alpha release. Neuroreport 13: 849-852, 2002.
13. Carreño-Müller E, Herrera AJ, de Pablos RM, Tomás-Camardiel M, Venero JL, Cano J and Machado A: Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia. J Neurochem 84: 1201-1214, 2003.
14. Möller T, Hanisch UK and Ransom BR: Thrombin-induced activation of cultured rodent microglia. J Neurochem 75: 1539-1547, 2000.
15. Choi SH, Joe EH, Kim SU and Jin BK: Thrombin-induced microglial activation produces degeneration of nigral dopaminergic neurons in vivo. J Neurosci 23: 5877-5886, 2003.
16. Ryu J, Pyo H, Jou I and Joe E: Thrombin induces NO release from cultured rat microglia via protein kinase C, mitogen-activated protein kinase, and NF-kappa B. J Biol Chem 275: 29955-29959, 2000.
17. Hanisch UK, van Rossum D, Xie Y, Gast K, Misselwitz R, Auriola S, Goldsteins G, Koistinaho J, Kettenmann H and Moller T: The microglia-activating potential of thrombin: the protease is not involved in the induction of proinflammatory cytokines and chemokines. J Biol Chem 279: 51880-51887, 2004.
18. Weinstein JR, Hong S, Kulman JD, Bishop C, Kuniyoshi J, Andersen H, Ransom BR, Hanisch UK and Möller T: Unraveling thrombin's true microglia-activating potential: markedly disparate profiles of pharmaceutical-grade and commercial-grade thrombin preparations. J Neurochem 95: 1177-1187, 2005.
19. Aloisi F, Ria F, Penna G and Adorini L: Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 160: 4671-4680, 1998.
20. Hansen MB, Nielsen K and Berg K: Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119: 203-210, 1989.
21. Suo Z, Wu M, Ameenuddin S, Anderson HE, Zoloty JE, Citron BA, Andrade-Gordon P and Festoff BW: Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J Neurochem 80: 655-666, 2002.
22. Naldini A, Bernini C, Pucci A and Carraro F: Thrombin-mediated IL-10 up-regulation involves protease-activated receptor(PAR)-1 expression in human mononuclear leukocytes. J Leukoc Biol 78: 736-744, 2005.
23. Blackhard BD, Emilsson K, Nguyen D, Teng W, Martelli AJ, Nystedt S, Sundelin J and Scarborough RM: Ligand cross-reactivity within the protease-activated receptor family. J Biol Chem 271: 16466-16471, 1996.
24. Hollenberg MD, Saifeddine M, al-Ani B and Kawabata A: Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol 75: 832-841, 1997.
25. Yang MS, Lee J, Ji KA, Min KJ, Lee MA, Jou I and Joe E: Thrombin induces suppressor of cytokine signaling 3 expression in brain microglia via protein kinase Cdelta activation. Biochem Biophys Res Commun 317: 811-816, 2004.
26. Elliott J and Johnston JA: SOCS: role in inflammation, allergy and homeostasis. Trends Immunol 25: 434-440, 2004.
27. Boven LA, Vergnolle N, Henry SD, Silva C, Imai Y, Holden J, Warren K, Hollenberg MD and Power C: Up-regulation of proteinase-activated receptor 1 expression in astrocytes during HIV encephalitis. J Immunol 170: 2638-2646, 2003.
28. Ishida Y, Nagai A, Kobayashi S and Kim SU: Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase. J Neuropathol Exp Neurol 65: 66-77, 2006.
29. Pompili E, Nori SL, Geloso MC, Guadagni E, Corvino V, Michetti F and Fumagalli L: Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus. Mol Brain Res 122: 93-98, 2004.
30. Pompili E, Fabrizi C and Fumagalli L: PAR-1 upregulation by trimethyltin and lipopolysaccharide in cultured rat astrocytes. Int J Mol Med 18: 33-39, 2006.
31. Hailer NP: Immunosuppression after traumatic or ischemic CNS damage: it is neuroprotective and illuminates the role of microglial cells. Prog Neurobiol 84: 211-233, 2008.
32. Hamill CE, Caudle WM, Richardson JR, Yuan H, Pennell K, Greene JG, Miller GW and Traynelis SF: Exacerbation of dopaminergic terminal damage in a mouse model of Parkinson's disease by the G-protein-coupled receptor protease-activated receptor 1. Mol Pharmacol 72: 653-664, 2007.
33. Shibata M, Kumar SR, Amar A, Fernandez JA, Hofman F, Griffin JH and Zlokovic BV: Anti-inflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation 103: 1799-1805, 2001.
34. Kaneider NC, Leger AJ, Agarwal A, Nguyen N, Perides G, Derian C, Covic L and Kuliopulos A:'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage. Nat Immunol 8: 1303-1312, 2007.
35. Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J, Derian CK, Andrade-Gordon P, Rosen H and Ruf W: Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452: 654-658, 2008.
36. Campbell IL: Cytokine-mediated inflammation, tumorigenesis, and disease-associated JAK/STAT/SOCS signaling circuits in the CNS. Brain Res Rev 48: 166-177, 2005.
37. Berlato C, Cassatella MA, Kinjyo I, Gatto L, Yoshimura A and Bazzoni F: Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J Immunol 168: 6404-6411, 2002.
38. Qasimi P, Ming-Lum A, Ghanipour A, Ong CJ, Cox ME, Ihle J, Cacalano N, Yoshimura A and Mui AL: Divergent mechanisms utilized by SOCS3 to mediate interleukin-10 inhibition of tumor necrosis factor alpha and nitric oxide production by macrophages. J Biol Chem 281: 6316-6324, 2006.